http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104168889-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2013-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104168889-B
titleOfInvention Obtain the method for pharmaceutical composition based on modafinil, the pharmaceutical composition of acquisition and application thereof
abstract The present invention relates to a kind of new method for obtaining pharmaceutical composition based on modafinil.The method is: be dissolved in the fluid of supercriticality by S modafinil;Then, after the pressure reducing described fluid, by making the absorption of described S modafinil reclaim described S modafinil on the surface of the substrate of particle form.Described fluid can be CO 2 Or another kind of solvent, and substrate can be Lactis Anhydrous or mannitol.This pharmaceutical composition needs in short-term the people taking described pharmaceutical composition and increases the application in the case of vigilance in the short time.
priorityDate 2012-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6348500-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID38874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID38874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136460

Total number of triples: 39.